NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $963,090 | -24.2% | 78,300 | -1.0% | 0.35% | -23.3% |
Q2 2023 | $1,271,137 | -4.6% | 79,100 | +3.4% | 0.45% | -11.7% |
Q1 2023 | $1,331,865 | +89.2% | 76,500 | +0.4% | 0.51% | +75.6% |
Q4 2022 | $704,088 | +17.0% | 76,200 | +9.0% | 0.29% | +14.6% |
Q3 2022 | $602,000 | +5.1% | 69,900 | -0.5% | 0.25% | +2.8% |
Q2 2022 | $573,000 | -27.9% | 70,285 | +7.4% | 0.25% | -11.5% |
Q1 2022 | $795,000 | -59.1% | 65,445 | +14.9% | 0.28% | -56.1% |
Q4 2021 | $1,943,000 | +32.8% | 56,945 | +87.8% | 0.64% | +26.4% |
Q3 2021 | $1,463,000 | +23.0% | 30,330 | +15.2% | 0.50% | +28.0% |
Q2 2021 | $1,189,000 | +5.7% | 26,330 | +12.9% | 0.39% | -5.1% |
Q1 2021 | $1,125,000 | -6.2% | 23,330 | +4.7% | 0.41% | -12.5% |
Q4 2020 | $1,200,000 | +158.1% | 22,280 | +76.8% | 0.47% | +115.0% |
Q3 2020 | $465,000 | +114.3% | 12,600 | +80.0% | 0.22% | +105.6% |
Q2 2020 | $217,000 | – | 7,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,612,363 | $55,014,000 | 24.06% |
PERKINS CAPITAL MANAGEMENT INC | 155,550 | $5,307,000 | 3.58% |
First Light Asset Management, LLC | 763,907 | $26,065,000 | 1.87% |
Bullseye Asset Management LLC | 108,054 | $3,617,000 | 1.44% |
Ranger Investment Management | 756,380 | $25,808,000 | 1.41% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,006,088 | $34,328,000 | 1.21% |
EMERALD ADVISERS, LLC | 885,436 | $30,211,000 | 1.12% |
Granite Investment Partners, LLC | 963,187 | $32,864,000 | 0.96% |
Nicholas Investment Partners, LP | 428,378 | $14,616,000 | 0.92% |
Redwood Investments, LLC | 335,054 | $11,432,000 | 0.90% |